http://rdf.ncbi.nlm.nih.gov/pubchem/patent/NZ-517119-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_708d963fc20f3e5e597e00e27eff99bf |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-715 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-727 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 |
| filingDate | 1998-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d420d0d31e4467533a0248ddd9549e18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b2256659d8839901b2aaf314987065ae http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_019326bc3f6b2b0cc8b62e5654eb315a |
| publicationDate | 2003-11-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | NZ-517119-A |
| titleOfInvention | Use of low-molecular-weight heparins for preventing and treating central nervous system (CNS) trauma |
| abstract | Use of a low molecular weight heparin for the treatment and or prevention of trauma of the central nervous system, excluding craniospinal trauma. The low molecular weight heparin may consist of: - oligosaccharides having a 2-0-sulpho-4-enopyranosuronic acid at one of their ends, - a low molecular weight heparin obtained by depolymerisation of a heparin ester by means of a base, or - a low molecular weight heparin selected from enoxaparin, nadroparin, parnaparin, reviparin, dalteparin, tinzaparin, danaparin, ardepari n, certoparin, CY222 and SR90107/ORG31540. |
| priorityDate | 1997-05-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 28.